Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Hand

Showing results (91-100 of 103) with videos related to

Pageof 11
Sort By:
Journal of Medicinal Chemistry|July 1, 1986
Novel 1,3-bis(aryloxy)propanes as leukotriene D4 antagonistsA F Kreft, D H Klaubert, S C Bell, et al.
Health Education & Behavior : the Official Publication of the Society for Public Health Education|October 26, 1999
Health care providers' perspectives on patient delay for seeking care for symptoms of acute myocardial infarctionJ Zapka, B Estabrook, J Gilliland, et al.
The American Review of Respiratory Disease|March 1, 1990
A comparison of alpha 1-proteinase inhibitor methoxysuccinyl-Ala-Ala-Pro-Val-chloromethylketone and specific beta-lactam inhibitors in an acute model of human polymorphonuclear leukocyte elastase-induced lung hemorrhage in the hamsterD S Fletcher, D G Osinga, K M Hand, et al.
The Journal of Biological Chemistry|January 13, 2006
Mutation of a conserved threonine in the third transmembrane helix of alpha- and beta-connexins creates a dominant-negative closed gap junction channelDerek L Beahm, Atsunori Oshima, Guido M Gaietta, et al.
Journal of Medicinal Chemistry|March 1, 1990
Antioxidant-based inhibitors of leukotriene biosynthesis. The discovery of 6-[1-[2-(hydroxymethyl)phenyl]-1-propen-3-yl]-2,3-dihydro-5- benzofuranol, a potent topical antiinflammatory agentM L Hammond, R A Zambias, M N Chang, et al.
Journal of Medicinal Chemistry|June 23, 1995
Orally active beta-lactam inhibitors of human leukocyte elastase. 3. Stereospecific synthesis and structure-activity relationships for 3,3-dialkylazetidin-2-onesP E Finke, S K Shah, D S Fletcher, et al.
Antimicrobial Agents and Chemotherapy|November 16, 2023
Subcutaneous infusion of high-dose benzathine penicillin G is safe, tolerable, and suitable for less-frequent dosing for rheumatic heart disease secondary prophylaxis: a phase 1 open-label population pharmacokinetic studyJoseph Kado, Sam Salman, Thel K Hla, et al.
The Journal of Antimicrobial Chemotherapy|April 17, 2019
A population pharmacokinetic study of benzathine benzylpenicillin G administration in children and adolescents with rheumatic heart disease: new insights for improved secondary prophylaxis strategiesRobert M Hand, Sam Salman, Nelly Newall, et al.
Pharmacology Research & Perspectives|October 22, 2020
Quality of benzathine penicillin G: A multinational cross-sectional studyRobert M Hand, S M D K Ganga Senarathna, Madhu Page-Sharp, et al.
Circulation|June 3, 2004
The clinician as investigator: participating in clinical trials in the practice settingEllis W Lader, Christopher P Cannon, E Magnus Ohman, et al.
Pageof 11

Showing results (91-100 of 103) with videos related to

Sort By:
Pageof 11
Journal of Medicinal Chemistry|July 1, 1986
Novel 1,3-bis(aryloxy)propanes as leukotriene D4 antagonistsA F Kreft, D H Klaubert, S C Bell, et al.
Health Education & Behavior : the Official Publication of the Society for Public Health Education|October 26, 1999
Health care providers' perspectives on patient delay for seeking care for symptoms of acute myocardial infarctionJ Zapka, B Estabrook, J Gilliland, et al.
The American Review of Respiratory Disease|March 1, 1990
A comparison of alpha 1-proteinase inhibitor methoxysuccinyl-Ala-Ala-Pro-Val-chloromethylketone and specific beta-lactam inhibitors in an acute model of human polymorphonuclear leukocyte elastase-induced lung hemorrhage in the hamsterD S Fletcher, D G Osinga, K M Hand, et al.
The Journal of Biological Chemistry|January 13, 2006
Mutation of a conserved threonine in the third transmembrane helix of alpha- and beta-connexins creates a dominant-negative closed gap junction channelDerek L Beahm, Atsunori Oshima, Guido M Gaietta, et al.
Journal of Medicinal Chemistry|March 1, 1990
Antioxidant-based inhibitors of leukotriene biosynthesis. The discovery of 6-[1-[2-(hydroxymethyl)phenyl]-1-propen-3-yl]-2,3-dihydro-5- benzofuranol, a potent topical antiinflammatory agentM L Hammond, R A Zambias, M N Chang, et al.
Journal of Medicinal Chemistry|June 23, 1995
Orally active beta-lactam inhibitors of human leukocyte elastase. 3. Stereospecific synthesis and structure-activity relationships for 3,3-dialkylazetidin-2-onesP E Finke, S K Shah, D S Fletcher, et al.
Antimicrobial Agents and Chemotherapy|November 16, 2023
Subcutaneous infusion of high-dose benzathine penicillin G is safe, tolerable, and suitable for less-frequent dosing for rheumatic heart disease secondary prophylaxis: a phase 1 open-label population pharmacokinetic studyJoseph Kado, Sam Salman, Thel K Hla, et al.
The Journal of Antimicrobial Chemotherapy|April 17, 2019
A population pharmacokinetic study of benzathine benzylpenicillin G administration in children and adolescents with rheumatic heart disease: new insights for improved secondary prophylaxis strategiesRobert M Hand, Sam Salman, Nelly Newall, et al.
Pharmacology Research & Perspectives|October 22, 2020
Quality of benzathine penicillin G: A multinational cross-sectional studyRobert M Hand, S M D K Ganga Senarathna, Madhu Page-Sharp, et al.
Circulation|June 3, 2004
The clinician as investigator: participating in clinical trials in the practice settingEllis W Lader, Christopher P Cannon, E Magnus Ohman, et al.
Pageof 11